Heat Biologics Joins Russell Microcap® Index

DURHAM, N.C., June 28, 2021 (GLOBE NEWSWIRE) — Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that it has been added to the Russell…

Click here to view the original article.